Host: |
Rabbit |
Applications: |
WB/IHC/IF/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Pachytene checkpoint protein 2 homolog (383-432 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000ELISA 1:10000IF 1:50-200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
TRIP13 |
Gene ID: |
9319 |
Uniprot ID: |
PCH2_HUMAN |
Immunogen Region: |
383-432 aa |
Specificity: |
TRIP13 Polyclonal Antibody detects endogenous levels of TRIP13 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human TRIP13 at the amino acid range 383-432 |
Protein Name | Pachytene Checkpoint Protein 2 HomologHuman Papillomavirus Type 16 E1 Protein-Binding Protein16e1-BpHpv16 E1 Protein-Binding ProteinThyroid Hormone Receptor Interactor 13Thyroid Receptor-Interacting Protein 13Tr-Interacting Protein 13Trip-13 |
Alternative Antibody Names | Anti-Pachytene Checkpoint Protein 2 Homolog antibodyAnti-Human Papillomavirus Type 16 E1 Protein-Binding Protein antibodyAnti-16e1-Bp antibodyAnti-Hpv16 E1 Protein-Binding Protein antibodyAnti-Thyroid Hormone Receptor Interactor 13 antibodyAnti-Thyroid Receptor-Interacting Protein 13 antibodyAnti-Tr-Interacting Protein 13 antibodyAnti-Trip-13 antibodyAnti-TRIP13 antibodyAnti-PCH2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance